In Reply: Dr Lohman's primary concern is that stratified care based on disability may lead to overtreatment with triptans. He indicates that when clinicians use stratified care, some patients who met minimal criteria for treatment success with aspirin plus metoclopramide may receive a triptan. Success in our trial was defined as achieving mild or no pain within 2 hours in 2 of 3 attacks. Treating a patient who achieves this level of success with a triptan may not constitute "overtreatment." In 1 study, less than 25% of patients with mild pain at 2 hours (a nominal success) were satisfied with their therapy.1 Contrary to Lohman's assertion, many patients who use triptans also use other agents; de-escalating treatment is common in clinical practice.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.